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Previewspairing of A domain and substrate through
the preparation of the corresponding
acyl-AMS probe. The next challenge
would be to further evolve the rest of the
NRPS assembly line to process the unnat-
ural building block efficiently.
The marriage of directed evolution and
natural product biosynthesis is a tanta-
lizing union toward production of ‘‘unnat-
ural’’ natural products. The difficulties
associated with high throughput screen-
ing of desired phenotypes have severely
limited progresses in this regard. Zhang
et al. (2013) demonstrated that powerful
techniques, such as yeast surface
display, which are widely used in the
protein engineering field, can be effec-
tively designed to allow rapid screening
of enzymes in secondary metabolism.This important work has only scratched
the surface. It is anticipated that addi-
tional ingenious approaches can signifi-
cantly improve our abilities to tailor the
properties of these enzymes toward
customized synthesis of target small
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Small molecule inhibitors of amyloid aggregation have potential as treatment for a variety of conditions. In
this issue of Chemistry & Biology, Romero and colleagues use amyloid-dependent B. subtilis biofilm
formation to screen for amyloid inhibitors, identifying compounds that not only inhibit B. subtilis biofilm
formation but also ones that disrupt preformed biofilms.Amyloid fibers are historically associated
with diseases such as Alzheimer’s, Hun-
tington, and the prion diseases. Many
proteins can adopt the amyloid confor-
mation—essentially a b-rich repeating
structure where the b strands orient
perpendicular to the fiber axis. Ordered
amyloid protein polymers upset cellular
proteostasis because they can inappro-
priately interact with membranes or
sequester chaperone machinery. There-
fore, the search is on for ways to amelio-
rate amyloid-related diseases by targeting
amyloid formation. A major hurdle in
this endeavor is that disease-associated
amyloid formation is sporadic and difficult
to faithfully reproduce inmodel organisms.However, a growing number of ‘‘func-
tional’’ amyloids have been identified that
are assembled by dedicated biogenesis
systems. Functional amyloids and their
assembly systems have been found in
nearly all walks of cellular life, including
mammals, fungi, and bacteria (Hammer
et al., 2008, Fowler et al., 2007). Functional
amyloids contribute to cellular biology
in various ways, including regulation of
melanin synthesis, information transfer,
or as a structural component. Further-
more, some of these functional amyloid
systems provide a unique platform for
understanding how amyloid formation
can be directed and controlled so that
cellular toxicity is minimized.Amyloids are commonly found as
the major protein component of the
extracellular matrix in bacterial biofilms.
Bacteria within the biofilm are protected
from environmental insults, including
disinfectants and antibiotics, making
biofilms a major concern in hospital
and industrial settings. Therefore, factors
that can disrupt bacterial amyloid
formation would be potential lead
compounds for targeting bacterial bio-
films or amyloid formation in general.
The study presented in this issue of
Chemistry & Biology by Romero et al.
(2013) describes Bacillus subtilis pellicle
biofilm as a model system to screen
for amyloid inhibitors. The extracellular13 ª2013 Elsevier Ltd All rights reserved 5
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Figure 1. Various Modes of Action of Amyloid Modulatory Molecules
(a) A typical amyloid pathway: during the rate-limiting, lag phase, unfolded monomeric proteins assemble
into conformationally dynamic oligomers. These oligomers can serve as seeds or templates that guide
mature amyloid formation.
(b) Inhibition at the monomer stage: the protein does not proceed to the oligomer intermediate.
(c) A molecule capable of disassembling preformed amyloid fibers.
(d) Stimulation of amyloid formation.
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Previewsmatrix of B. subtilis biofilms consist of
two components, the exopolysaccharide
and the amyloidogenic protein TasA
(Branda et al., 2006). Two small chemical
molecules that inhibit biofilm formation
by targeting the extracellular amyloid
component of B. subtilis biofilms were
identified. Importantly, one of the
compounds not only inhibited biofilm
formation but also disassembled already
formed B. subtilis biofilms. Anti-biofilm
compounds with distinct modes of
action can be used synergistically to
increase the potency of inhibition. The
two inhibitory compounds described by
Romero et al. (2013) created an even
stronger inhibitory effect when allowed
to exert their effect simultaneously.
Collaboration between molecules may
allow one type of molecule to dissolve
preformed fibers, while another molecule6 Chemistry & Biology 20, January 24, 2013 ªcould discourage new fiber formation
(Figure 1).
Utilizing functional amyloids as a tool
for identifying general amyloid inhibitors
has produced several promising leads in
recent years. Strategic design of small
compounds as amyloid modulators and
thorough investigation of their effect
on numerous amyloidogenic proteins
is a promising approach to battle the
threat of amyloid influence on health.
One example of strategic design is the
use of a small library of fluorescent
compounds designed to interact with
amyloid pathways based on structure-
activity information (Chorell et al., 2012).
This approach presents an opportunity
to gain specific information on the
systems studied by observing the inter-
actions of the molecules and the amyloid
protein or the cellular compartment. In2013 Elsevier Ltd All rights reservedthe case of E. coli and biofilm formation,
molecules have been discovered that
inhibit both curli formation and type
1-pili assembly, two protein structures
that contribute to biofilm formation
(Cegelski et al., 2009). Finally, another
promising approach to screen for
amyloid modulators makes use of the
E. coli curli export system to assemble
extracellular amyloid fibers of human
disease-associated huntingtin or yeast
prion proteins (Sivanathan and Hochs-
child, 2012). This provides an opportunity
to screen for molecules affecting forma-
tion of the amyloid fibers.
The two molecules identified by
Romero et al. (2013) seem thus far to
be general amyloid inhibitors, as they
were able to inhibit biofilm formation by
B. subtilis, E. coli, and Bacillus cereus.
However, it is interesting to note that
a molecule that inhibits amyloid formation
by one protein may have a different effect
on other proteins, including the ability
to stimulate amyloid formation (Horvath
et al., 2012). The two inhibitory molecules
had no effect on Staphylococcus aureus
biofilm even though S. aureus has been
shown toproduce functional amyloids that
stabilize biofilm architecture (Schwartz
et al., 2012). This might suggest that the
compounds identified by Romero et al.
(2013) are specific for certain amyloids
or that the conditions in which the
S. aureus biofilms were grown for this
study do not require an amyloid matrix.
Full understanding of the specificity of
these compounds and their biological
activities will be a fascinating future
direction for this work.
Clearly, Romero et al. (2013) have
paved the way for capitalizing on a well-
understood biofilm system to easily
screen and identify new compounds that
ameliorate amyloid formation.ACKNOWLEDGMENTS
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